General Announcement for PLC

25/02/2022

OTHERS Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd and Bio-Innova Co. Ltd

PHARMANIAGA BERHAD

Type Announcement
Subject OTHERS
Description 
Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd and Bio-Innova Co. Ltd

The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Research Centre Sdn Bhd, a wholly-owned subsidiary of the Company has on 25 February 2022 entered into a Memorandum of Understanding (“MOU”) with Bio-Innova Co. Ltd. to establish a basis of co-operation and collaboration between the parties in relation to clinical trials, including bioavailability and bioequivalence studies as well as on building capabilities in the area of product development.

Please refer to the attachment for details of the announcement.

This announcement is dated 25 February 2022.


Please refer attachment below.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 25 Feb 2022
Category General Announcement for PLC
Reference Number GA1-23022022-00060


Related Announcements for PHARMA
Date Title
30/03/2022 OTHERS Memorandum of Understanding between Pharmaniaga Manufacturing Berhad and Prime Medical Store L.L.C
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Lifescience Sdn Bhd & Bionet Asia Co. Ltd.
11/01/2022 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
30/12/2021 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
01/11/2021 MEMORANDUM OF UNDERSTANDING Pharmaniaga Berhad ("Pharmaniaga" or "the Company") Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd, a wholly-owned subsidiary of the Company and National Institutes of Biotechnology Malaysia.
12/08/2021 OTHERS Surat Setuju Terima for the Supply and Distribution of Covid-19 Vaccine Coronavac Suspension for Injection between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Government of Malaysia.
07/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
06/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
19/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") PROPOSED BONUS ISSUE
10/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR ''COMPANY'') PROPOSED BONUS ISSUE